Company
SkinBioTherapeutics PLC
LON:SBTX
SkinBioTherapeutics PLC is a life science company focused on skin health. The company’s proprietary platform technology, SkinBiotix ® , is based upon discoveries made at The University of Manchester.
156 stories · page 1 of 2
SkinBioTherapeutics puzzled by share price, says feedback positive for psoriasis treatment
In today’s statement, it said: “The team continues to focus on driving sales of AxisBiotix-Ps".
SkinBioTherapeutics CEO says company still at start of the journey as initial sales of psoriasis product miss expectations
“We're still at a very early stage of the sales journey, however, it's clear from the customer feedback that AxisBiotix-Ps is a product that has already had a very positive impact,” CEO Stuart Ashman told investors
SkinBioTherapeutics beefs up the board
The company has appointed a full-time CFO and an expert in marketing fast-moving consumer goods
SkinBio to use social media influencers to accelerate launch of psoriasis treatment
Psoriasis brand AxisBiotix-Ps is hoped to reach at least 1.2 million people on social media
SkinBioTherapeutics seeks full-time finance chief and NED to guide social media strategy
The company aiming to appoint a replacement CFO early in the second quarter to ensure an orderly handover
Xmas tips contest for 2021 wrapped up by small cap pick
Watch out for the new edition for 2022 coming in the next week or two, including a number of new competitors
SkinBioTherapeutics CEO hails 2021 as 'landmark year'
“We have transformed ourselves from a research and product development business to a commercial one," said CEO Stuart Ashman
Proactive News round-up: SkinBioTherapeutics, Alpha Growth, Afarak....
A selection of the stories appearing today on the Proactive website
SkinBioTherapeutics launches food supplement aimed at alleviating psoriasis
Today is World Psoriasis Day so it's a good day for SkinBio to launch AxisBiotix-Ps in the UK and the US
SkinBioTherapeutics to launch psoriasis targeting food supplement on October 29
AxisBiotix-Ps was described as delivering "tremendous results" for sufferers of the skin condition during a study conducted earlier this year
SkinBioTherapeutics gears up for launch of psoriasis treatment in Q4; product could have applications across a range of skin conditions
AxisBiotix may have applications for eczema, acne and rosacea, the company said
Investment tips for 2021: small cap pick extends lead at half-way stage
All of the investments are in positive territory and all the tipsters are sticking with their current choices as they look to catch the leader
SkinBioTherapeutics says psoriasis study exceeds expectations as it moves into commercial phase for the food supplement
The breakthrough was developed by the company's subsidiary in collaboration with partner Winclove Probiotic
SkinBioTherapeutics targets oral care with University of Manchester collaboration
“This new strand to our development portfolio also presents near-term opportunities," said chief executive Stuart Ashman
SkinBioTherapeutics starts collaboration with University of Manchester to focus on skin inflammation treatments
The idea of the partnership is to find products ripe for commercialisation
Investment tips for 2021: small cap pick takes early lead in first quarter
We asked a group of market professionals and investment writers for their top picks for 2021 - this is the first update
Fintel slips after the release of its full-year results is delayed by a week
A look at some of the major movers in London on Monday
SkinBioTherapeutics expects significant progress in lead projects this year
The life sciences company had a comfortable cash position of £5.5mln as of December 31
SkinBioTherapeutics starts food supplement consumer study with more participants than planned
The additional 65 places are for patients suffering from non-psoriatic conditions to explore the possible impact of probiotics on other skin conditions
SkinBioTherapeutics continues working on its partnerships
Here we take a closer look at SkinBioTherapeutics, the life sciences group that is using bacteria to improve people’s skin
SkinBioTherapeutics expands food supplement study after receiving an "extraordinary" number of applications
A further 50 people will participate, taking the number to 250
SkinBioTherapeutics says AxisBiotix subsidiary has commenced enrolment for its food supplement consumer study
A proprietary blend of bacterial strains has been specifically designed to balance the gut microbiome to address the overproduction of new skin cells often seen in aggressive skin conditions such as psoriasis
SkinBioTherapeutics preparing to kick off psoriasis study as it eyes a busy year
Financially, the group remains well placed. It finished the 12 months to June 30, 2020, with £2.2mln in the bank and topped this up last month with a further £4.45mln from a placing and open offer
SkinBioTherapeutics boosts fundraise by £450,000 through open offer
Acceptances for the offer, which was priced at 16p, amounted to 2.8mln shares
SkinBioTherapeutics looks forward to first revenues in 2021
The junior life sciences firm is making good progress with Winclove Probiotics and Croda
SkinBioTherapeutics raises £4mln to accelerate development
As well as a placing at 16p a share, the firm has organised an open offer of stock that could bring in an additional £500,000
SkinBioTherapeutics appoints Dr Jonathan Sheffield as a senior medical advisor with immediate effect
Since 2010, Dr Sheffield formerly served as the CEO of the National Institute for Health Research (NIHR), Clinical Research Network, which delivers clinical research studies throughout the NHS in England covering primary, secondary and tert
SkinBioTherapeutics reports progress in cosmetic programme and food supplement trial
The ‘self managed’ psoriasis food supplement trial is expected to accelerate the timing of readout and allow for a “significantly earlier commercial launch than originally planned”
SkinBioTherapeutics targets the promising skin microbiome market
The life sciences firm studies how to enhance and reintroduce the good bacteria on the skin
SkinBioTherapeutics says development project with Winclove is well ahead of schedule
The skin health specialist made significant progress with its collaborative partners, Winclove Probiotics and Croda
SkinBioThereapeutics making progress with new strategy
The company is targeting further commercial progress in the areas of MediBiotix, where it is focusing on medical device applications, and CleanBiotix
SkinBioTherapeutics strikes development agreement to create psoriasis supplement
The UK skin health group teaming up with a Dutch firm called Winclove Probiotics
SkinBio sets out five channels for developing skin health technology
At the end of June, there was £3.1mln in the bank, compared to £3.2mln a year earlier
Archive
Proactive snapshot: SkinBioTherapeutics, Argentex, European Metals
A look at some of the top stories from the Proactive newswire on Wednesday
SkinBioTherapeutics teams up with Croda for first commercial deal
The company will be working with Croda unit Sederma, which will design and manufacture “new unique, sustainable, cosmetic ingredients, focusing specifically on the growing skincare actives market”
Archive
Proactive news snapshot: Argo Blockchain, ValiRx, Arc Minerals, Directa Plus ...
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Distil down the plug-hole after slump in revenues
A look at the day's major movers, including C&C, Global Ports, Carclo, ValiRx, IGas, Intelligent Ultrasound, Richland Resources and Bango
SkinBioTherapeutics looks to make progress with commercial talks as new CEO takes charge
New chief executive Stuart Ashman was appointed to take the company to commercialisation
Investments and investor services
FTSE 100 closes a shade lower as markets uninspired; US celebrates Independence Day holiday
The Footsie finished down nearly six points at 7,603
SkinBioTherapeutics makes progress with SkinBiotix platform
The SkinBiotix platform uses lysates (extracts) of probiotic bacteria to help increase the integrity of the skin as a barrier against toxins and other harmful elements while also improving its healing rate and infection resistance
Archive
Proactive news snapshot: ANGLE, Galantas Gold, SkinBioTherapeutics …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Trifast finishes financial year with a flourish
A look at the day's major movers, including Mi-Pay, D4T4, First Derivatives, Starcom, Ferro-Alloy Resources, SimiGon and MX Oil.
SkinBioTherapeutics appoints soon-to-be CEO to the board
SkinBio said Stuart John Ashman’s appointment would allow him to gain an understanding of the business while incumbent CEO Dr Cath O’Neill would focus on the company’s scientific developments and ongoing commercial discussions
Archive
FTSE 100 closes lower ahead of the Easter weekend
The UK's premier stock index finished down around 11 points at 7,459
Archive
Proactive news snapshot: Anglo Asian Mining, Scancell, Circle Property …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Totally jumps as healthcare provider flags contract awards in upbeat trading statement
A look at some of the day's major movers, including Totally, Ascent Resources , Firestone Diamonds, Adept4, LightwaveRF and Adept4
SkinBioTherapeutics chief "really pleased" with human trial data for new skin cream
“It is very difficult to change a healthy barrier and therefore the data showing improvement in some age groups gives us confidence in our partner discussions, and in seeking to develop future applications in disease conditions where the ba
Archive
Proactive news snapshot: Midatech Pharma, Curzon Energy, Ariana Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Midatech Pharma soars after receiving Spanish backing
A look at the day's major movers, including Zambeef, GAN, Bowleven, Serabi Gold, Mobile Streams, Ascent Resources and FireAngel
SkinBioTherapeutics names ex-Smith & Nephew sales boss as new CEO
Regulatory due diligence checks still need to be carried out, but the plan is for Stuart Ashman to take over from Cath O’Neill
Investments and investor services
FTSE 100 closes in positive territory as MPs vote down May's deal again
Footsie closed at 7,279, up nearly 45 points on the day
Archive
Proactive news snapshot: Sound Energy, Strategic Minerals, Anglo African Oil & Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Vela surges as it increases stake in Argo Blockchain
A look at the day's major movers, including Andalas Energy, Botswana Diamonds, Sirius Petroleum, Tri-Star Resources, Zinc Media, Realm Therapeutics and Croma Security
SkinBioTherapeutics raises £1.5mln from existing investor
Seneca Partners’ holding in the company increases to 20.9% from 14.6% after it bought stock at 16 pence
Investments and investor services
FTSE 100 closes in red amid lower volumes but Reckitt Benckiser jumps
Footsie closed down around 17 points at 7,219 but FTSE 250 added over 140 at 19,127
Investments and investor services
Edenville Energy plunges after Tanzanian setback
A look at the day's major movers, including Sabien technology, Stock Spirits, Simigon,UK Oil & Gas, Tungsten, WANdisco, Restaurant Group and Titon
Archive
Proactive news snapshot: Strategic Minerals, Feedback, Redx Pharma …
A glance at some of the day's highlights from the Proactive Investors newswire
SkinBioTherapeutics looking for new CEO as it moves into the commercial phase
Dr Cath O'Neill told investors: "I am determined to find a suitable individual for the CEO role with the same passion for the science, as well as commercial acumen"
Archive
FTSE 100 closes a tad higher but sentiment dented by US data
FTSE 100 closed up just over six points at 7,197, while FTSE 250 shed over 74 at 18,898
Archive
Proactive news snapshot: BigDish, ValiRx, Oriole Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Sylvania Platinum fails to flatten 'em - the sceptics, that is - with its production update
A look at the day's major movers, including Cambridge Cognition, SRT Marine, Redhall, FireAngel, Challenger Acquisitions, Alexander Mining and Blue Star Capital
SkinBioTherapeutics human trial on track
Data yielded will be assessed to determine the effectiveness of the group’s SkinBiotix technology
Archive
Proactive news snapshot: Highlands Natural Resources, Simec Atlantis Energy, W Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
AO and Ei in alphabeti-spaghetti shoot-out
A look at the day's fireballs and furballs, including AO, Ei, Nakama, BTG, KCom and CYBG
SkinBioTherapeutics begins final phase of human study; commercial talks continue
Provisional results for some of the volunteers will be available by the end of December with the full read-out expected in the first quarter of next year
Archive
Proactive news snapshot: 88 Energy, Highlands Natural Resources, SkinBioTherapeutics …
A glance at some of the day's highlights from the Proactive Investors newswire
Big Sofa Technologies shares rise as it appoints new chief executive
A look at some of the biggest risers and fallers in the London market on Tuesday
SkinBioTherapeutics says initial portions of human trial deliver "positive results"
The tests, which are the precursor to the main element of the study, assessed irritancy and moisturisation potential
FTSE 100 closes higher as markets are relieved after US midterm election
The UK's premier benchmark index finished over 76 points higher, or 1.09%, at 7,117
Archive
Proactive news snapshot: Horizonte Minerals, Oriole Resources, Eckoh …
A glance at some of the day's highlights from the Proactive Investors newswire
KAZ Minerals on track to hit upper-end of gold and silver output forecasts
Some of the main news-driven risers and fallers in London on Thursday …
SkinBioTherapeutics boss praises “significant progress” made with moisturising cream this year
The cream is currently undergoing its first-in-human studies, with researchers assessing its skin irritancy, moisturisation potential and skin barrier function
FTSE 100 closes at session peak after strong rebound in tandem with US stocks
At the close, the UK blue chip index was 41.12 points higher at 7,004.10, the session peak, and well above the early low of 6,995.99
Archive
Proactive news snapshot: Pan African Resources, Strategic Minerals, Strategic Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Mission Marketing Group shares step up, United Carpets declines
A look at some of the biggest risers and fallers in the UK market on Wednesday
SkinBioTherapeutics first-in-human trial of cream underway
The first data should start coming through next month
Investments and investor services
FTSE 100 closes higher as trade fears ebb; Kingfisher leads the laggards
The FTSE 100 closed nearly 31 points higher at 7,331, while FTSE 250 added over 42 at 20,500
Well-received interim results boost Biome Technologies and Gamma Communications
A look at some of the biggest risers and fallers in London on Monday
Archive
Proactive news snapshot: Hurricane Energy, SkinBioTherapeutics, Tissue Regenix …
A glance at some of the day's highlights from the Proactive Investors newswire
SkinBioTherapeutics cream successful in stability testing
Demonstrating the extended stability of the cream formulation was a key step to commencing the human study - chief executive, Dr Cath O’Neill
FTSE 100 sails higher, bolstered by stumbling sterling
The UK blue-chip index finished up over 72 points at 7,504, while the mid-cap FTSE 250 was also higher
Investments and investor services
Moneysupermarket, RHI Magnesita and Rank slow FTSE 250's advance
A look at the day's big share price movements,featuring RHI Magnestia, Rank, Kaz Minerals, Moneysupermarket.com, GoCompare.com, Kingfisher, Ashley House, Marhsalls, Online Blockchain, Green & Smart, Abzena and On the Beach
Archive
Proactive news snapshot: Abzena, SkinBioTherapeutics, Shanta Gold …
A glance at some of the day's highlights from the Proactive Investors newswire
SkinBioTherapeutics successfully scales-up manufacturing
SkinBioTherapeutics' platform applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to the skin